Davide Moi

818 total citations
32 papers, 609 citations indexed

About

Davide Moi is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Davide Moi has authored 32 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Organic Chemistry, 19 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in Davide Moi's work include Enzyme function and inhibition (10 papers), Synthesis and Catalytic Reactions (10 papers) and Synthesis and biological activity (7 papers). Davide Moi is often cited by papers focused on Enzyme function and inhibition (10 papers), Synthesis and Catalytic Reactions (10 papers) and Synthesis and biological activity (7 papers). Davide Moi collaborates with scholars based in Italy, Germany and Saudi Arabia. Davide Moi's co-authors include Gianfranco Balboni, Valentina Onnis, Andrea Citarella, Silvia Vertuani, Anna Baldisserotto, Ilaria Lampronti, Stefano Manfredini, Monica Demurtas, Claudiu T. Supuran and Giulio Rastelli and has published in prestigious journals such as Chemical Communications, Pain and Journal of Medicinal Chemistry.

In The Last Decade

Davide Moi

28 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Davide Moi Italy 15 398 331 94 93 76 32 609
Radwan El‐Haggar Egypt 14 505 1.3× 382 1.2× 96 1.0× 79 0.8× 52 0.7× 28 695
Marwa G. El‐Gazzar Egypt 17 622 1.6× 310 0.9× 79 0.8× 99 1.1× 53 0.7× 42 789
В. Г. Карцев Russia 15 558 1.4× 302 0.9× 84 0.9× 40 0.4× 34 0.4× 99 768
Aiten M. Soliman Egypt 21 701 1.8× 452 1.4× 49 0.5× 147 1.6× 67 0.9× 34 882
Rasha Z. Batran Egypt 16 557 1.4× 201 0.6× 148 1.6× 66 0.7× 71 0.9× 29 736
Julia Morizzi Australia 12 492 1.2× 279 0.8× 61 0.6× 61 0.7× 58 0.8× 17 703
Venkatasubramanian Ulaganathan India 16 280 0.7× 346 1.0× 39 0.4× 60 0.6× 34 0.4× 38 712
Yassin M. Nissan Egypt 19 749 1.9× 336 1.0× 144 1.5× 53 0.6× 72 0.9× 37 884
Mahamadhanif S. Shaikh South Africa 11 390 1.0× 185 0.6× 82 0.9× 50 0.5× 42 0.6× 25 562
Osama I. El‐Sabbagh Egypt 14 645 1.6× 168 0.5× 76 0.8× 37 0.4× 65 0.9× 27 753

Countries citing papers authored by Davide Moi

Since Specialization
Citations

This map shows the geographic impact of Davide Moi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Moi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Moi more than expected).

Fields of papers citing papers by Davide Moi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Moi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Moi. The network helps show where Davide Moi may publish in the future.

Co-authorship network of co-authors of Davide Moi

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Moi. A scholar is included among the top collaborators of Davide Moi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Moi. Davide Moi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moi, Davide, Simone Carradori, Marialucia Gallorini, et al.. (2025). Investigation on Human Carbonic Anhydrase IX and XII Inhibitory Activity and A549 Antiproliferative Activity of a New Class of Coumarinamides. Pharmaceuticals. 18(3). 372–372. 1 indexed citations
3.
Citarella, Andrea, Davide Moi, Lucas Ruberto, et al.. (2024). Synthesis of α-fluorocinnamate derivatives as novel cathepsin S inhibitors with in vitro antiproliferative activity against pancreatic cancer cells. Bioorganic & Medicinal Chemistry. 115. 117987–117987. 3 indexed citations
4.
Chianese, Annalisa, Vanessa Palmas, Carla Zannella, et al.. (2024). Exploring the Antiviral Potential of Esters of Cinnamic Acids with Quercetin. Viruses. 16(5). 665–665. 4 indexed citations
5.
Moi, Davide, Serena Vittorio, Andrea Angeli, Claudiu T. Supuran, & Valentina Onnis. (2024). Discovery of a New Class of 1-(4-Sulfamoylbenzoyl)piperidine-4-carboxamides as Human Carbonic Anhydrase Inhibitors. ACS Medicinal Chemistry Letters. 15(4). 470–477. 4 indexed citations
6.
Citarella, Andrea, Davide Moi, Helena Pérez‐Peña, et al.. (2023). Synthesis of SARS-CoV-2 Mpro inhibitors bearing a cinnamic ester warhead with in vitro activity against human coronaviruses. Organic & Biomolecular Chemistry. 21(18). 3811–3824. 23 indexed citations
7.
Citarella, Andrea, Davide Moi, Helena Pérez‐Peña, et al.. (2023). Discovery of a Novel Trifluoromethyl Diazirine Inhibitor of SARS-CoV-2 Mpro. Molecules. 28(2). 514–514. 6 indexed citations
8.
Citarella, Andrea, Davide Moi, Daniele Passarella, et al.. (2023). Recent Advances in SARS-CoV-2 Main Protease Inhibitors: From Nirmatrelvir to Future Perspectives. Biomolecules. 13(9). 1339–1339. 27 indexed citations
9.
Moi, Davide, Serena Vittorio, Andrea Angeli, et al.. (2022). Investigation on Hydrazonobenzenesulfonamides as Human Carbonic Anhydrase I, II, IX and XII Inhibitors. Molecules. 28(1). 91–91. 10 indexed citations
10.
Dettori, Tinuccia, Giuseppina Sanna, Gabriele Serreli, et al.. (2022). Synthesis and Antiproliferative Effect of Halogenated Coumarin Derivatives. Molecules. 27(24). 8897–8897. 8 indexed citations
11.
12.
Baldisserotto, Anna, Monica Demurtas, Ilaria Lampronti, et al.. (2020). In-Vitro Evaluation of Antioxidant, Antiproliferative and Photo-Protective Activities of Benzimidazolehydrazone Derivatives. Pharmaceuticals. 13(4). 68–68. 17 indexed citations
13.
Nocentini, Alessio, Davide Moi, Alessandro Deplano, et al.. (2019). Sulfonamide/sulfamate switch with a series of piperazinylureido derivatives: Synthesis, kinetic and in silico evaluation as carbonic anhydrase isoforms I, II, IV, and IX inhibitors. European Journal of Medicinal Chemistry. 186. 111896–111896. 17 indexed citations
14.
Morgen, Michael, Peter Sehr, Raphael R. Steimbach, et al.. (2019). Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated. Journal of Medicinal Chemistry. 62(9). 4426–4443. 66 indexed citations
15.
Moi, Davide, Paul Foster, Alessandro Deplano, et al.. (2019). Synthesis and in vitro evaluation of piperazinyl-ureido sulfamates as steroid sulfatase inhibitors. European Journal of Medicinal Chemistry. 182. 111614–111614. 11 indexed citations
16.
Demurtas, Monica, Anna Baldisserotto, Ilaria Lampronti, et al.. (2019). Indole derivatives as multifunctional drugs: Synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity of indole hydrazones. Bioorganic Chemistry. 85. 568–576. 97 indexed citations
17.
Moi, Davide, Alessio Nocentini, Alessandro Deplano, et al.. (2019). Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation. European Journal of Medicinal Chemistry. 182. 111638–111638. 30 indexed citations
18.
Nocentini, Alessio, et al.. (2018). Discovery of thiazolin-4-one-based aromatic sulfamates as a new class of carbonic anhydrase isoforms I, II, IV, and IX inhibitors. Bioorganic Chemistry. 77. 293–299. 26 indexed citations
20.
Baldisserotto, Anna, Monica Demurtas, Ilaria Lampronti, et al.. (2018). Benzofuran hydrazones as potential scaffold in the development of multifunctional drugs: Synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity. European Journal of Medicinal Chemistry. 156. 118–125. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026